Holen Sie sich die Stockscreener-App
132.04
0.69%
0.91
Handel nachbörslich:
132.75
0.71
+0.54%
Schlusskurs vom Vortag:
$131.13
Offen:
$132.09
24-Stunden-Volumen:
994.80K
Relative Volume:
0.91
Marktkapitalisierung:
$4.50B
Einnahmen:
$401.09M
Nettoeinkommen (Verlust:
$32.64M
KGV:
140.47
EPS:
0.94
Netto-Cashflow:
$-120.51M
1W Leistung:
+11.14%
1M Leistung:
+17.41%
6M Leistung:
+85.40%
1J Leistung:
-18.49%
1-Tages-Spanne:
$127.70
$133.54
1-Wochen-Bereich:
$114.30
$133.54
52-Wochen-Spanne:
$55.00
$177.37
Transmedics Group Inc Stock (TMDX) Company Profile
Firmenname
Transmedics Group Inc
Sektor
Branche
Telefon
(978) 552-0900
Adresse
200 MINUTEMAN ROAD, ANDOVER, MA
Vergleichen Sie TMDX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TMDX
Transmedics Group Inc
|
132.04 | 4.34B | 401.09M | 32.64M | -120.51M | 0.94 |
|
ABT
Abbott Laboratories
|
129.40 | 228.03B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.50 | 152.09B | 18.49B | 2.51B | 3.23B | 1.68 |
|
SYK
Stryker Corp
|
378.95 | 143.98B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.91 | 117.98B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.68 | 45.17B | 5.69B | 4.14B | 577.90M | 6.96 |
Transmedics Group Inc Stock (TMDX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-17 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-11-22 | Herabstufung | Needham | Buy → Hold |
| 2024-10-29 | Bestätigt | Needham | Buy |
| 2024-10-29 | Bestätigt | Oppenheimer | Outperform |
| 2024-09-24 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-08-21 | Eingeleitet | Needham | Buy |
| 2024-06-06 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-06-04 | Eingeleitet | Stephens | Overweight |
| 2024-03-28 | Eingeleitet | Piper Sandler | Overweight |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2022-08-02 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-10-08 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-04-07 | Eingeleitet | Oppenheimer | Outperform |
| 2019-05-28 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-05-28 | Eingeleitet | Cowen | Outperform |
| 2019-05-28 | Eingeleitet | JP Morgan | Overweight |
| 2019-05-28 | Eingeleitet | Morgan Stanley | Equal-Weight |
Alle ansehen
Transmedics Group Inc Aktie (TMDX) Neueste Nachrichten
TransMedics Group, Inc. (NASDAQ:TMDX) Shares Acquired by Montanaro Asset Management Ltd - MarketBeat
What Technical Tools Say About TransMedics Group Inc. RecoveryOil Prices & Short-Term Trading Alerts - 선데이타임즈
Headlands Technologies LLC Sells 2,903 Shares of TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat
When is the best time to buy TransMedics Group Inc. stockFree Stock Portfolio Allocation Guidance - Newser
Can TransMedics Group Inc. hit a new high this monthYield Curve Outlook and Long-Term Implication Summary - Newser
How TransMedics Group Inc. stock performs during market volatility [Weekly Loss Report]Free AI Powered Market Trend Analysis - Newser
How to monitor TransMedics Group Inc. with trend dashboardsFree Daily Chart Pattern Stock Forecast - Newser
Live market analysis of TransMedics Group Inc.Pattern Breakout Tracker with Screener Tools - Newser
TransMedics Group (NASDAQ:TMDX) Shares Gap UpHere's What Happened - MarketBeat
Transmedics Group Inc (TMDX) Stock: A Year of Stock Market Ups and Downs - investchronicle.com
TransMedics Group, Inc. (TMDX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
TransMedics Q2 2025 slides: revenue surges 38%, company raises full-year guidance By Investing.com - Investing.com South Africa
TransMedics Q2 2025 slides: revenue surges 38%, company raises full-year guidance - Investing.com Nigeria
TransMedics (TMDX) Recently Broke Out Above the 50-Day Moving Average - Yahoo Finance
Exit strategy if you’re trapped in TransMedics Group Inc.Investment Position Summary with Timeframe Forecast - Newser
TransMedics Group Joins Elite List Of Stocks With 95-Plus Composite Rating - Investor's Business Daily
Next-Gen Heart Trial and Raised Outlook Might Change the Case for Investing in TransMedics (TMDX) - Yahoo Finance
Order flow analysis tools used on TransMedics Group Inc.Trade Plan With Low Risk High Return - Newser
TransMedics Soars 11% on $270M Volume Surge Jumps Into Top 500 Stocks as Earnings Outlook and FDA Approval Drive Momentum - AInvest
Surge in TransMedics: Are Big Gains Ahead? - StocksToTrade
TransMedics Group’s Unexpected Growth: A Closer Look - timothysykes.com
Spotlight on TransMedics Group: Analyzing the Surge in Options ActivityTransMedics Group (NASDAQ:TMDX) - Benzinga
Hedge Fund and Insider Trading News: Carl Icahn, Ken Griffin, Warren Buffett, Bill Ackman, Schonfeld Strategic Advisors, TransMedics Group Inc (TMDX), Carvana Co (CVNA), and More - Insider Monkey
TransMedics rises after CEO buys company stock - MSN
TransMedics rises after CEO buys company stock (TMDX:NASDAQ) - Seeking Alpha
TransMedics Shares Surge on Positive FDA Approval for Heart Trial - StocksToTrade
Insider Buying Report: TransMedics Group CEO and Pinnacle Financial Partners Director Purchase Shares - AInvest
TransMedics Stock Climbs After FDA Approval Sparks Optimism - timothysykes.com
Published on: 2025-08-11 17:55:02 - beatles.ru
TransMedics Group Inc. stock momentum explainedVolume Confirmed Setup with Entry Confidence - Newser
Is TransMedics Group Inc. a candidate for recovery playConservative Equity Setup with Signal Analysis - Newser
Why TransMedics Group Inc. is moving todayFast Entry Strategy with Price Prediction - Newser
Institutional scanner results for TransMedics Group Inc.ROI Focused Setup With Drawdown Analysis - Newser
TransMedics Group Inc. stock trend forecastDaily Exit and Entry Price Prediction - Newser
Using data tools to time your TransMedics Group Inc. exitEntry Optimization Guide with Volume Analysis - Newser
Bronstein, Gewirtz & Grossman, LLC Is Investigating TransMedics Group, Inc. (TMDX) And Encourages Investors to Connect - ACCESS Newswire
TransMedics Group, Inc. (NASDAQ:TMDX) Q2 2025 Earnings Call Transcript - MSN
Developing predictive dashboards with TransMedics Group Inc. dataFree Early Breakout Entry Point Notifications - Newser
Blair William & Co. IL Sells 105,569 Shares of TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat
Will TransMedics Group Inc. outperform the marketValue Investing Summary and Earnings Outlook - Newser
TransMedics Group, Inc. (NASDAQ:TMDX) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Can trapped investors hope for a rebound in TransMedics Group Inc.Trend Following Ideas with Volume Confirmation - Newser
TransMedics Group CEO Makes Significant Stock Purchase, Boosting Investor Confidence - AInvest
Why TransMedics Group Stocks Are Soaring - TipRanks
Applying Wyckoff theory to TransMedics Group Inc. stockFree Capital Efficiency Optimized Stock Alerts - Newser
CEO’s Bold Move: Major Stock Purchase Signals Confidence in TransMedics - TipRanks
TransMedics Sees Its Earnings Soar - AOL.com
TransMedics Group CEO Hassanein Waleed H buys 16835 shares at $118.68/share. - AInvest
TransMedics Group (NASDAQ:TMDX) Stock Price Up 6.8% on Analyst Upgrade - MarketBeat
Advanced analytics toolkit walkthrough for TransMedics Group Inc.Daily Market Entry Strategy with Tools - Newser
Allianz Asset Management GmbH Takes Position in TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat
Finanzdaten der Transmedics Group Inc-Aktie (TMDX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Transmedics Group Inc-Aktie (TMDX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Hassanein Waleed H | President & CEO |
Aug 07 '25 |
Buy |
116.25 |
8,475 |
985,209 |
486,234 |
| Basile Edward M | Director |
Aug 04 '25 |
Option Exercise |
0.70 |
4,143 |
2,900 |
7,009 |
| Basile Edward M | Director |
Aug 04 '25 |
Sale |
125.51 |
4,143 |
519,988 |
2,866 |
0.31%
1.36%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):